Medical device companies – including Sientra, Endologix and Invacare – won loans from the US government’s Paycheck Protection Program, intended to protect jobs during the coronavirus pandemic. In total, nearly 1,400 device makers collected as much as $1.6bn, according to a Medtech Insight analysis of PPP data.

Japanese authority approves St. Jude’s MRI-safe pacemaker and Edwards’ Sapien XT, the first transcatheter aortic valve approved in that country. More new products.

A large, undertreated patient population makes the urinary incontinence market an attractive arena for manufacturers; however, looming changes to the product approval process have added a level of uncertainty about future market growth.

Urinary incontinence is a growing health problem with increasing social and economic significance--the direct and indirect costs of treating it total almost $20 billion in the US alone. Device companies are providing a variety of treatment options for patients with UI, including a growing number of increasingly less invasive surgical options.